Oppenheimer & Co’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,048
| Closed | -$210K | – | 1585 |
|
|
2021
Q2 | $210K | Buy |
+4,048
| New | +$210K | ﹤0.01% | 1405 |
|
|
2020
Q4 | – | Sell |
-4,631
| Closed | -$201K | – | 1415 |
|
|
2020
Q3 | $201K | Sell |
4,631
-390
| -8% | -$16.9K | 0.01% | 1159 |
|
|
2020
Q2 | $216K | Buy |
+5,021
| New | +$216K | 0.01% | 1090 |
|
|
2018
Q4 | – | Sell |
-4,114
| Closed | -$200K | – | 1375 |
|
|
2018
Q3 | $200K | Sell |
4,114
-1,866
| -31% | -$90.7K | 0.01% | 1232 |
|
|
2018
Q2 | $257K | Sell |
5,980
-142
| -2% | -$6.1K | 0.01% | 1123 |
|
|
2018
Q1 | $256K | Sell |
6,122
-3,356
| -35% | -$140K | 0.01% | 1122 |
|
|
2017
Q4 | $413K | Sell |
9,478
-97
| -1% | -$4.23K | 0.01% | 935 |
|
|
2017
Q3 | $407K | Buy |
9,575
+1,412
| +17% | +$60K | 0.01% | 924 |
|
|
2017
Q2 | $351K | Buy |
8,163
+745
| +10% | +$32K | 0.01% | 967 |
|
|
2017
Q1 | $310K | Buy |
7,418
+1,401
| +23% | +$58.5K | 0.01% | 985 |
|
|
2016
Q4 | $235K | Buy |
6,017
+1,433
| +31% | +$56K | 0.01% | 1097 |
|
|
2016
Q3 | $203K | Buy |
+4,584
| New | +$203K | 0.01% | 1138 |
|
|
2016
Q1 | – | Sell |
-4,848
| Closed | -$248K | – | 1331 |
|
|
2015
Q4 | $248K | Sell |
4,848
-2,928
| -38% | -$150K | 0.01% | 1030 |
|
|
2015
Q3 | $364K | Buy |
7,776
+3,336
| +75% | +$156K | 0.01% | 924 |
|
|
2015
Q2 | $276K | Buy |
4,440
+48
| +1% | +$2.98K | 0.01% | 1129 |
|
|
2015
Q1 | $271K | Sell |
4,392
-354
| -7% | -$21.8K | 0.01% | 1142 |
|
|
2014
Q4 | $256K | Sell |
4,746
-454
| -9% | -$24.5K | 0.01% | 1097 |
|
|
2014
Q3 | $275K | Buy |
5,200
+850
| +20% | +$45K | 0.01% | 1110 |
|
|
2014
Q2 | $226K | Sell |
4,350
-672
| -13% | -$34.9K | 0.01% | 1199 |
|
|
2014
Q1 | $235K | Sell |
5,022
-60
| -1% | -$2.81K | 0.01% | 1159 |
|
|
2013
Q4 | $224K | Buy |
+5,082
| New | +$224K | 0.01% | 1159 |
|